Figure 2From: Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndromeCirculating levels of interleukin-18 (IL-18) and adiponectin in patients with metabolic syndrome before and after lifestyle modification. *P < 0.05 for baseline vs. after lifestyle modification in patients with metabolic syndrome.Back to article page